Safety Study of CALAA-01 to Treat Solid Tumor Cancers
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Cancer|Solid Tumor
Interventions: DRUG: CALAA-01
Sponsor: Calando Pharmaceuticals